Search

Your search keyword '"Yousef, Zaheer"' showing total 269 results
Start Over Author "Yousef, Zaheer"
269 results on '"Yousef, Zaheer"'

8. A Multicenter External Validation of a Score Model to Predict Risk of Events in Patients With Brugada Syndrome

Author

Chow, Ji-Jian, Leong, Kevin M.W., Yazdani, Momina, Huzaien, Hani W., Jones, Sian, Shun-Shin, Matthew J., Koa-Wing, Michael, Lefroy, David C., Lim, Phang Boon, Linton, Nicholas W.F., Ng, Fu Siong, Qureshi, Norman A., Whinnett, Zachary I., Peters, Nicholas S., O'Callaghan, Peter, Yousef, Zaheer, Kanagaratnam, Prapa, and Varnava, Amanda M.

Published
2021
Full Text
View/download PDF

10. Optimizing heart failure pathways to enhance patient care: the Program to Optimize Heart Failure Patient Pathways (PRO‐HF).

Author

Patwala, Ashish, Barker, Diane, Da Costa, Antoine, Bayard, Geoffrey, Brunner‐La Rocca, Hans‐Peter, Fontes‐Carvalho, Ricardo, De la Fuente, Luis, Goralski, Marc, Mahon, Niall G., Roque, David, Santos, Mario, Yousef, Zaheer, Ben Hamouda, Hela, Teal, Mark, Christory, François, Ahmed, Fozia Zahir, and Mebazaa, Alexandre

Subjects
HEART failure patients, MEDICAL personnel, PATIENT monitoring, HEART failure, INPATIENT care
Abstract

Aims: Many European healthcare providers struggle to adopt multidisciplinary, integrated care pathways for people with heart failure (HF) as recommended by the European Society of Cardiology. PRO‐HF (Program to Optimize Heart Failure Patient Pathways) was developed to help clinicians identify strengths, gaps, and shortcomings in their HF pathways and support tailored interventions to optimize pathways and enhance patient care. We report initial findings from baseline assessments of HF pathway characteristics and challenges from 10 hospitals in six European countries (France, Ireland, Portugal, Spain, The Netherlands, and United Kingdom). Methods and results: Baseline assessments were holistic appraisals of full HF services to calibrate current status and development needs and assist management teams in prioritizing improvement projects. Assessments were performed using a comprehensive checklist of measures covering the HF patient journey from diagnosis to ongoing follow‐up. These included a digital survey sent to full HF care teams and one‐to‐one interviews. The digital survey focused on four key areas (HF outpatient clinic; remote patient management; efficient device implantation and inpatient pathways; and network maximization) and 16 dimensions of excellence. Priority areas and themes for action identified in baseline assessments were (i) provision of HF specialist care; (ii) data capture and analysis; (iii) institutional care protocols; (iv) hospital‐wide strategies; and (v) multidisciplinary teams (MDTs). Suboptimal specialist care of emergency inpatients was an issue at all hospitals and prioritized at 8/10. Availability and accessibility of data on patients, activities, and outcomes was an issue at all hospitals and prioritized by 4/10. A lack of clear protocols, templates, and tools for some HF activities created variability in patient care (e.g., HF specialist consultations, diagnostic testing, follow‐up appointments, medications, and device eligibility) and inefficient use of clinician time. This made it difficult to initiate new technologies (e.g., remote patient monitoring) due to the risk of overburdening staff. MDTs were frequently understaffed. Multiple interventions were identified to address gaps and shortcomings that could be tailored to specific needs of individual hospitals (e.g., inpatient pathway optimization, creation/optimization of HF outpatient clinics, development of an HF performance dashboard, enhancement of protocol adherence, streamlining cardiac resynchronisation therapy pathways, and MDT coordination). Conclusions: PRO‐HF provides a valuable opportunity to identify gaps and significant shortcomings in HF pathways in European hospitals. Preliminary findings from hospitals that have initiated suggested changes to address these challenges are encouraging, though longer‐term follow‐up from more hospitals is needed to confirm the impact of PRO‐HF on HF pathway optimization and patient care. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

12. Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial

Author

Bartunek, Jozef, Bondue, Antoine, Van Craenenbroeck, Emeline, Kubanek, Milos, Zemanek, David, Jensen, Morten, Mogensen, Jens, Thune, Jens Jakob, Charron, Philippe, Hagege, Albert, Lairez, Olivier, Trochu, Jean-Noël, Axthelm, Christoph, Duengen, Hans-Dirk, Frey, Norbert, Mitrovic, Veselin, Preusch, Michael, Schulz-Menger, Jeanette, Seidler, Tim, Arad, Michael, Halabi, Majdi, Katz, Amos, Monakier, Daniel, Paz, Offir, Viskin, Samuel, Zwas, Donna, Olivotto, Iacopo, Brunner-La Rocca, Hans Peter, Michels, Michelle, Dudek, Dariusz, Oko-Sarnowska, Zofia, Oreziak, Artur, Wojakowski, Wojciech, Cardim, Nuno, Pereira, Helder, Barriales-Villa, Roberto, García Pavia, Pablo, Gimeno Blanes, Juan, Hidalgo Urbano, Rafael, Rincón Diaz, Luis Miguel, Elliott, Perry, Yousef, Zaheer, Abraham, Theodore, Afshar, Kia, Alvarez, Paulino, Bach, Richard, Becker, Richard, Choudhury, Lubna, Fermin, David, Jacoby, Daniel, Jefferies, John, Kramer, Christopher, Lakdawala, Neal, Lester, Steven, Marian, Ali, Masri, Ahmad, Maurer, Mathew, Nagueh, Sherif, Owens, Anjali, Owens, David, Rader, Florian, Saberi, Sara, Sherrid, Mark, Shirani, Jamshid, Symanski, John, Turer, Aslan, Wang, Andrew, Wever-Pinzon, Omar, Wheeler, Matthew, Wong, Timothy, Yamani, Mohamad, Abraham, Theodore P, Garcia-Pavia, Pablo, Lakdawala, Neal K, Wheeler, Matthew T, Jensen, Morten K, Gimeno-Blanes, Juan, Myers, Jonathan, Hegde, Sheila M, Solomon, Scott D, Sehnert, Amy J, Zhang, David, Li, Wanying, Bhattacharya, Mondira, Edelberg, Jay M, Waldman, Cynthia Burstein, Lester, Steven J, and Ho, Carolyn Y

Published
2020
Full Text
View/download PDF

14. Multicenter Randomized Controlled Crossover Trial Comparing Hemodynamic Optimization Against Echocardiographic Optimization of AV and VV Delay of Cardiac Resynchronization Therapy: The BRAVO Trial

Author

Whinnett, Zachary I., Sohaib, S.M. Afzal, Mason, Mark, Duncan, Edward, Tanner, Mark, Lefroy, David, Al-Obaidi, Mohamed, Ellery, Sue, Leyva-Leon, Francisco, Betts, Tim, Dayer, Mark, Foley, Paul, Swinburn, Jon, Thomas, Martin, Khiani, Raj, Wong, Tom, Yousef, Zaheer, Rogers, Dominic, Kalra, Paul R., Dhileepan, Vignesh, March, Katherine, Howard, James, Kyriacou, Andreas, Mayet, Jamil, Kanagaratnam, Prapa, Frenneaux, Michael, Hughes, Alun D., and Francis, Darrel P.

Published
2019
Full Text
View/download PDF

21. Thrombin generation is associated with extracellular vesicle and leukocytes membranes in acute coronary syndrome.

Author

Protty, Majd B, primary, Tyrrell, Victoria J, additional, Allen-Redpath, Keith, additional, Soyama, Shin, additional, Hajeyah, Ali A, additional, Costa, Daniela, additional, Choudhury, Anirban, additional, Mitra, Rito, additional, Yaqoob, Parveen, additional, Jenkins, P Vince, additional, Yousef, Zaheer, additional, Collins, Peter W, additional, and O'Donnell, Valerie, additional

Published
2023
Full Text
View/download PDF

22. Withdrawn as duplicate: Optimized Implementation of cardiac resynchronization therapy – a call for action for referral and optimization of care

Author

Mullens, Wilfried, Auricchio, Angelo, Martens, Pieter, Witte, Klaus, Cowie, Martin R, Delgado, Victoria, Dickstein, Kenneth, Linde, Cecilia, Vernooy, Kevin, Leyva, Francisco, Bauersachs, Johann, Israel, Carsten W, Lund, Lars, Donal, Erwan, Boriani, Giuseppe, Jaarsma, Tiny, Berruezo, Antonio, Traykov, Vassil, Yousef, Zaheer, Kalarus, Zbigniew, Cosedis Nielsen, Jens, Steffel, Jan, Vardas, Panos, Coats, Andrew, Seferovic, Petar, Edvardsen, Thor, Heidbuchel, Hein, Ruschitzka, Frank, Leclercq, Christophe, Mullens, Wilfried, Auricchio, Angelo, Martens, Pieter, Witte, Klaus, Cowie, Martin R, Delgado, Victoria, Dickstein, Kenneth, Linde, Cecilia, Vernooy, Kevin, Leyva, Francisco, Bauersachs, Johann, Israel, Carsten W, Lund, Lars, Donal, Erwan, Boriani, Giuseppe, Jaarsma, Tiny, Berruezo, Antonio, Traykov, Vassil, Yousef, Zaheer, Kalarus, Zbigniew, Cosedis Nielsen, Jens, Steffel, Jan, Vardas, Panos, Coats, Andrew, Seferovic, Petar, Edvardsen, Thor, Heidbuchel, Hein, Ruschitzka, Frank, and Leclercq, Christophe

Abstract

This article has been withdrawn due to a publisher error that caused the article to be duplicated. The definitive version of this article is published under https://doi.org/10.1093/europace/euaa411.

Published
2023

26. Cardiac care of children with dystrophinopathy and females carrying DMD-gene variations

Author

Bourke, John, primary, Turner, Cathy, additional, Bradlow, William, additional, Chikermane, Ashish, additional, Coats, Caroline, additional, Fenton, Matthew, additional, Ilina, Maria, additional, Johnson, Alexandra, additional, Kapetanakis, Stam, additional, Kuhwald, Lisa, additional, Morley-Davies, Adrian, additional, Quinlivan, Ros, additional, Savvatis, Konstantinos, additional, Schiava, Marianela, additional, Yousef, Zaheer, additional, and Guglieri, Michela, additional

Published
2022
Full Text
View/download PDF

31. Using reconditioned pacemakers to treat bradycardia in Africa

Author

Wunderly, Kevin, Yousef, Zaheer, Bonny, Aimé, Weatherwax, Kevin J., Lavan, Balasundaram, Allmendinger, Craig, Wasserman, Brad, Samson, George, Davis, Sheldon, Nel, George, Russell, James, Akwanalo, Constantine, Sani, Mahmoud U., Chin, Ashely, Ajijola, Olujimi A., Mayosi, Bongani M., Eagle, Kim A., and Crawford, Thomas C.

Published
2018
Full Text
View/download PDF

32. The Utility and Educational Impact of a Virtual Webinar to Deliver an International Undergraduate Cardiovascular Conference

Author

Ganesananthan,Sashiananthan, Zahid,Abeer, Choudhry,Anam, Vadiveloo,Thivya V, Khan,Nailah, Yang,Ting, Urrehman,Haroon, Mahesh,Sahana, Yousef,Zaheer, Ganesananthan,Sashiananthan, Zahid,Abeer, Choudhry,Anam, Vadiveloo,Thivya V, Khan,Nailah, Yang,Ting, Urrehman,Haroon, Mahesh,Sahana, and Yousef,Zaheer

Abstract

Sashiananthan Ganesananthan,1,2 Abeer Zahid,2 Anam Choudhry,2 Thivya V Vadiveloo,2 Nailah Khan,2 Ting Yang,2 Haroon Urrehman,2 Sahana Mahesh,2 Zaheer Yousef2– 4 1National Heart and Lung Institute, Imperial College London, London, UK; 2Cardiff University School of Medicine, Cardiff University, Cardiff, Wales, UK; 3Department of Cardiology, University Hospital Wales, Cardiff, Wales, UK; 4Welsh Heart Research Institute, Cardiff University, Cardiff, Wales, UKCorrespondence: Sashiananthan Ganesananthan, National Heart and Lung Institute, Imperial College London, London, UK, Email sashiganes96@yahoo.co.ukIntroduction: Conferences are an important avenue for dissemination of knowledge, research and provide networking opportunities for career development. The COVID-19 pandemic has prompted adoption of virtual platforms for delivery of these conferences. The aim of the study was to determine the utility and educational impact of a student-led virtual webinar to deliver an undergraduate cardiovascular conference compared to a traditional in-person conference.Methods: We conducted a two-day virtual conference using the Zoom platform in June 2021. The conference consisted of cardiology subspecialty lectures, and workshops were conducted by a junior doctor, senior cardiology trainees and consultants. The conference also outlaid a virtual poster hall and oral presentation session while networking opportunities were encouraged using breakout rooms and poster hall chat function. A 38-item self-administered online questionnaire was designed and disseminated at the end of the conference to all attending delegates. All data analysis and data visualisation strategies were conducted on R statistical programming.Results: Eight-hundred and forty students from 55 countries attended the event. Four hundred and ninety participants (58.5% response rate, 55.9% female) completed the questionnaire. Factors such as weekend conference (84.9%), student-led or organised (84.1%), environmental/sust

Published
2022

35. Optimized implementation of cardiac resynchronization therapy: a call for action for referral and optimization of care: A joint position statement from the Heart Failure Association (HFA), European Heart Rhythm Association (EHRA), and European Association of Cardiovascular Imaging (EACVI) of the European Society of Cardiology

Author

Mullens, Wilfried, Auricchio, Angelo, Martens, Pieter, Witte, Klaus, Cowie, Martin R., Delgado, Victoria, Dickstein, Kenneth, Linde, Cecilia, Vernooy, Kevin, Leyva, Francisco, Bauersachs, Johann, Israel, Carsten W., Lund, Lars H., Donal, Erwan, Boriani, Giuseppe, Jaarsma, Tiny, Berruezo, Antonio, Traykov, Vassil, Yousef, Zaheer, Kalarus, Zbigniew, Cosedis Nielsen, Jens, Steffel, Jan, Vardas, Panos, Coats, Andrew, Seferovic, Petar, Edvardsen, Thor, Heidbüchel, Hein, Ruschitzka, Frank, Leclercq, Christophe, University of Zurich, Mullens, Wilfried, Cardiologie, MUMC+: MA Med Staf Spec Cardiologie (9), RS: Carim - H06 Electro mechanics, and RS: Carim - H01 Clinical atrial fibrillation

Subjects
genetic structures, IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR, Vascular damage Radboud Institute for Health Sciences [Radboudumc 16], Heart failure, 610 Medicine & health, Health Services Misuse, 2705 Cardiology and Cardiovascular Medicine, 2737 Physiology (medical), LONG-TERM OUTCOMES, Disease management, Humans, Disease modification, PERMANENT ATRIAL-FIBRILLATION, ATRIOVENTRICULAR JUNCTION ABLATION, Referral and Consultation, EXPERT CONSENSUS STATEMENT, Outcome, Cardiac resynchronization therapy, Implementation, Care pathways, Disease Modification, Response, Utilization, ANGIOTENSIN-NEPRILYSIN INHIBITION, NONSUSTAINED VENTRICULAR-TACHYCARDIA, 2016 ESC GUIDELINES, Treatment Outcome, Critical Pathways, Quality of Life, 10209 Clinic for Cardiology, Human medicine, REDUCED EJECTION FRACTION, BUNDLE-BRANCH BLOCK
Abstract

Contains fulltext : 235382.pdf (Publisher’s version ) (Open Access) Cardiac resynchronization therapy (CRT) is one of the most effective therapies for heart failure with reduced ejection fraction and leads to improved quality of life, reductions in heart failure hospitalization rates and all-cause mortality. Nevertheless, up to two-thirds of eligible patients are not referred for CRT. Furthermore, post-implantation follow-up is often fragmented and suboptimal, hampering the potential maximal treatment effect. This joint position statement from three European Society of Cardiology Associations, Heart Failure Association (HFA), European Heart Rhythm Association (EHRA) and European Association of Cardiovascular Imaging (EACVI), focuses on optimized implementation of CRT. We offer theoretical and practical strategies to achieve more comprehensive CRT referral and post-procedural care by focusing on four actionable domains: (i) overcoming CRT under-utilization, (ii) better understanding of pre-implant characteristics, (iii) abandoning the term 'non-response' and replacing this by the concept of disease modification, and (iv) implementing a dedicated post-implant CRT care pathway.

Published
2021

36. Optimized Implementation of cardiac resynchronization therapy: a call for action for referral and optimization of care::A joint position statement from the Heart Failure Association (HFA), European Heart Rhythm Association (EHRA), and European Association of Cardiovascular Imaging (EACVI) of the European Society of Cardiology

Author

Mullens, Wilfried, Auricchio, Angelo, Martens, Pieter, Witte, Klaus, Cowie, Martin R, Delgado, Victoria, Dickstein, Kenneth, Linde, Cecilia, Vernooy, Kevin, Leyva, Francisco, Bauersachs, Johann, Israel, Carsten W, H. Lund, Lars, Donal, Erwan, Boriani, Giuseppe, Jaarsma, Tiny, Berruezo, Antonio, Traykov, Vassil, Yousef, Zaheer, Kalarus, Zbigniew, Cosedis Nielsen, Jens, Steffel, Jan, Vardas, Panos, Coats, Andrew, Seferovic, Petar, Edvardsen, Thor, Heidbuchel, Hein, and Ruschitzka, Frank

Subjects
HEART-FAILURE PATIENTS, Cardiac resynchronization therapy, genetic structures, IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR, Response, Heart failure, ANGIOTENSIN-NEPRILYSIN INHIBITION, NONSUSTAINED VENTRICULAR-TACHYCARDIA, Utilization, LONG-TERM OUTCOMES, Care pathways, Implementation, Disease management, cardiovascular system, Disease modification, PERMANENT ATRIAL-FIBRILLATION, ATRIOVENTRICULAR JUNCTION ABLATION, REDUCED EJECTION FRACTION, EXPERT CONSENSUS STATEMENT, Outcome, BUNDLE-BRANCH BLOCK
Abstract

Cardiac resynchronization therapy (CRT) is one of the most effective therapies for heart failure with reduced ejection fraction and leads to improved quality of life, reductions in heart failure hospitalization rates and all-cause mortality. Nevertheless, up to two-thirds of eligible patients are not referred for CRT. Furthermore, post-implantation follow-up is often fragmented and suboptimal, hampering the potential maximal treatment effect. This joint position statement from three European Society of Cardiology Associations, Heart Failure Association (HFA), European Heart Rhythm Association (EHRA) and European Association of Cardiovascular Imaging (EACVI), focuses on optimized implementation of CRT. We offer theoretical and practical strategies to achieve more comprehensive CRT referral and post-procedural care by focusing on four actionable domains: (i) overcoming CRT under-utilization, (ii) better understanding of pre-implant characteristics, (iii) abandoning the term 'non-response' and replacing this by the concept of disease modification, and (iv) implementing a dedicated post-implant CRT care pathway.

Published
2021
Full Text
View/download PDF

40. Effect of right ventricular pacing lead site on left ventricular function in patients with high-grade atrioventricular block: results of the Protect-Pace study

Author

Kaye, Gerald C., Linker, Nicholas J., Marwick, Thomas H., Pollock, Lucy, Graham, Laura, Pouliot, Erika, Poloniecki, Jan, Gammage, Michael, Kaye, Gerald, Martin, Paul, Pepper, Chris, Tang, Kare, Crozier, Ian, Goode, Graham, Young, Glenn, Petkar, Sanjiv, Langford, Ed, Linker, Nicholas John, Rozkovec, Adrian, Rinaldi, Aldo, Yousef, Zaheer, Lever, Nigel, Denman, Russell, Young, Glen, Williams, Ian, and McGavigan, Andrew

Published
2015
Full Text
View/download PDF

41. Optimising the Heart Failure Treatment Pathway: The Role of SGLT2 Inhibitors

Author

Evans, Marc, primary, Morgan, Angharad R., additional, Yousef, Zaheer, additional, Ellis, Gethin, additional, Dashora, Umesh, additional, Patel, Dipesh C., additional, Brown, Pam, additional, Hanif, Wasim, additional, Townend, Johnathan N., additional, Kanumilli, Naresh, additional, Moore, Jim, additional, Wilding, John P. H., additional, and Bain, Stephen C., additional

Published
2021
Full Text
View/download PDF

42. Optimized implementation of cardiac resynchronization therapy: a call for action for referral and optimization of care

Author

Mullens, Wilfried, primary, Auricchio, Angelo, additional, Martens, Pieter, additional, Witte, Klaus, additional, Cowie, Martin R, additional, Delgado, Victoria, additional, Dickstein, Kenneth, additional, Linde, Cecilia, additional, Vernooy, Kevin, additional, Leyva, Francisco, additional, Bauersachs, Johann, additional, Israel, Carsten W, additional, Lund, Lars H, additional, Donal, Erwan, additional, Boriani, Giuseppe, additional, Jaarsma, Tiny, additional, Berruezo, Antonio, additional, Traykov, Vassil, additional, Yousef, Zaheer, additional, Kalarus, Zbigniew, additional, Nielsen, Jens Cosedis, additional, Steffel, Jan, additional, Vardas, Panos, additional, Coats, Andrew, additional, Seferovic, Petar, additional, Edvardsen, Thor, additional, Heidbuchel, Hein, additional, Ruschitzka, Frank, additional, and Leclercq, Christophe, additional

Published
2021
Full Text
View/download PDF

46. Evaluation of the AirgloveTM, An Air-Regulated Thermal-Venodilatory Device Facilitating the Cannulation of Patients With Difficult Venous Access

Author

D'Cruz, Leon Gerard, primary, Gardiner, Elaine, additional, Shukla, Priyank, additional, Dickson, Dianne M., additional, Malaquias, Tiago M., additional, Johnstone, Scott, additional, Yousef, Zaheer, additional, Lai, Chris D, additional, Jack, Sheena, additional, Husain, Syed Arshad, additional, and Lai, Francis Anthony, additional

Published
2021
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results